[Molecular pathogenesis of ocular vascular disease--anti-angiogenesis as a therapeutic concept]. [electronic resource]
- Deutsche medizinische Wochenschrift (1946) Jun 2007
- 1268-72 p. digital
Publication Type: Journal Article; Review
1439-4413
10.1055/s-2007-982025 doi
Angiogenesis Inhibitors--therapeutic use Antibodies, Monoclonal--therapeutic use Antibodies, Monoclonal, Humanized Aptamers, Nucleotide--therapeutic use Bevacizumab Diabetic Angiopathies--drug therapy Diabetic Retinopathy--drug therapy Humans Infant, Newborn Macular Degeneration--drug therapy Neovascularization, Pathologic--drug therapy Ranibizumab Retinal Diseases--drug therapy Retinopathy of Prematurity--drug therapy Vascular Diseases--drug therapy